Clinical Trial: Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients

U.S., March 3 -- ClinicalTrials.gov registry received information related to the study (NCT07441733) titled 'Evaluate the Implementation of Using Indocyanine Green for Sentinel Lymph Node Mapping in Breast Cancer Patients' on Feb. 11.

Brief Summary: This single-institution pilot study uses a pre- and post-implementation design to evaluate the implementation of ICG fluorescent imaging for sentinel lymph node biopsy (SLNB) in an Italian hospital.

Study Start Date: Nov. 07, 2024

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: PROCEDURE: ICG used as a tracer for sentinel lymph node

ICG used as a tracer for sentinel lymph node instead of technetium 99

PROCEDURE: technetium 99 used as a tracer for sentinel lymph node

t...